Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local trial is testing a potential new medication to see if it may reduce recurrent diarrhea, kidney stones, diarrhea, frequent fevers, and/or eye pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease medical research study to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe UC (including associated symptoms such as abdominal cramping, growth failure, rectal pain, frequent fevers and/or eye pain), consider one of our Crohn’s disease studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s and UC flare-ups? Local CD clinical trial is testing a potential new medication to see if it may reduce urgency to defecate, stomach pain, cramps, frequent fevers, and/or joint pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the CD clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for 2–17 years of age to join a Crohn’s disease (CD) medical research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderately to severely active IBD (including associated symptoms such as tiredness, loss of appetite, constant need to poop, malnutrition and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease (CD) study is testing a potential new medication to see if it may reduce joint pain, fatigue, constant need to poop, weight loss, and/or joint pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for 2–17 years of age to join a clinical trial to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderate to severe Crohn’s disease (including associated symptoms such as weight loss, blood in the stool, abdominal pain, chronic fatigue and/or canker sores), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce recurrent diarrhea, diarrhea, abdominal pain, frequent fevers, and/or canker sores associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for young people at least 2 years of age but under 18 to join a Crohn’s disease (CD) research to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or CD and UC (including associated symptoms such as recurrent diarrhea, fever, diarrhea, chronic fatigue and/or canker sores), consider one of our research. All eligible participants will receive no-cost study-related care and study medication. Your young people at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing inflammatory bowel disease flare-ups? Local Crohn’s disease medical research study is testing a potential new medication to see if it may reduce urgency to defecate, fistula, diarrhea, malnutrition, and/or anemia associated with inflammatory bowel disease.
If you’re concerned about how inflammatory bowel disease affects your child’s life, find out more about the Crohn’s disease medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for 2–17 years of age to join a Crohn’s disease clinical research to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or CD and UC (including associated symptoms such as cramping, perianal fistula, constant need to poop, malnutrition and/or joint pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.